Lower-middle income (World Bank) vs Singapore: Hypertension effective treatment coverage (controlled hypertension)
Lower-middle income (World Bank)
14.3%
in 2019
Singapore
37.6%
in 2019
Lower-middle income (World Bank) rank
8th
Singapore rank
11th
Hypertension effective treatment coverage (controlled hypertension) over time
- Lower-middle income (World Bank)
- Singapore
How they compare
Singapore currently reports 37.6% against 14.3% in Lower-middle income (World Bank), a difference of 23.3%.
That makes Singapore's figure about 2.6 times Lower-middle income (World Bank)'s.
Across all 30 years both countries report, Singapore has been ahead every year.
Lower-middle income (World Bank) ranks 8th and Singapore ranks 11th of 11 groups.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.0% | 6.6% | 3.6% | Singapore |
| 2000s | 6.2% | 16.4% | 10.1% | Singapore |
| 2010s | 11.5% | 31.5% | 20.0% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Lower-middle income (World Bank) or Singapore?
- Singapore, at 37.6% against 14.3% in Lower-middle income (World Bank) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Lower-middle income (World Bank) and Singapore?
- 23.3%, with Singapore ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do Lower-middle income (World Bank) and Singapore rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Lower-middle income (World Bank) ranks 8th and Singapore ranks 11th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.